-
Article
Open AccessSARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
COVID-19 vaccines have been recommended to people with multiple sclerosis (pwMS) and, to ensure durable immunity, a third booster dose has been administered in several countries. Data about potential risks ass...
-
Article
Open AccessManagement of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
Patients with multiple sclerosis (MS) often receive disease-modifying therapies (DMTs) that can expose them to reactivation of potential occult hepatitis B virus (HBV) infection (pOBI). We aimed to evaluate th...
-
Article
Open AccessCorrection to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
-
Article
Open AccessPredictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
Dimethyl fumarate (DMF) is an oral drug approved for Relapsing Multiple Sclerosis (RMS) patients. Grade III lymphopenia is reported in 5–10% DMF-treated patients. Data on lymphocyte count (ALC) recovery after ...
-
Article
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study
Patients with multiple sclerosis on long-term injectable therapies may suffer from the so-called “needle fatigue”, i.e., a waning commitment to continue with the prescribed injectable treatment. Therefore, alt...
-
Article
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study
In this independent, multicenter, retrospective study, we investigated the short-term persistence to treatment with first-line self-injectable or oral disease-modifying treatments (DMTs) in patients with relap...
-
Article
Systematic assessment and characterization of chronic pain in multiple sclerosis patients
Pain is one of the most disabling clinical symptoms in patients with multiple sclerosis (MS). Several studies have already assessed the prevalence of pain in MS patients, reporting variable results, probably d...
-
Article
Open AccessPrevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems
Compared with other areas of the country, very limited data are available on multiple sclerosis (MS) prevalence in Central Italy. We aimed to estimate MS prevalence in the Lazio region and its geographical dis...
-
Article
Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder
-
Article
Erratum to: Both trigeminal autonomic cephalalgia and trigeminal neuralgia in a child
-
Article
Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?
The spinal cord can be affected by multiple heterogeneous disorders often difficult to diagnose. We describe ten patients affected by a progressive ascending myelopathy with a poor prognosis. The patients, dur...
-
Article
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer
-
Article
Demyelinating encephalomyeloradiculitis with Balò-like lesions